These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 21767154)
21. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas. Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820 [TBL] [Abstract][Full Text] [Related]
22. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Dupin N; Fisher C; Kellam P; Ariad S; Tulliez M; Franck N; van Marck E; Salmon D; Gorin I; Escande JP; Weiss RA; Alitalo K; Boshoff C Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4546-51. PubMed ID: 10200299 [TBL] [Abstract][Full Text] [Related]
23. Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2. Chen D; Gao Y; Nicholas J J Virol; 2014 Jan; 88(2):1025-38. PubMed ID: 24198402 [TBL] [Abstract][Full Text] [Related]
24. Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Parravicini C; Chandran B; Corbellino M; Berti E; Paulli M; Moore PS; Chang Y Am J Pathol; 2000 Mar; 156(3):743-9. PubMed ID: 10702388 [TBL] [Abstract][Full Text] [Related]
25. An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease. Uldrick TS; Wang V; O'Mahony D; Aleman K; Wyvill KM; Marshall V; Steinberg SM; Pittaluga S; Maric I; Whitby D; Tosato G; Little RF; Yarchoan R Clin Infect Dis; 2010 Aug; 51(3):350-8. PubMed ID: 20583924 [TBL] [Abstract][Full Text] [Related]
26. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117 [TBL] [Abstract][Full Text] [Related]
27. Linking KSHV to human cancer. Wong EL; Damania B Curr Oncol Rep; 2005 Sep; 7(5):349-56. PubMed ID: 16091195 [TBL] [Abstract][Full Text] [Related]
28. Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders. Aoki Y; Yarchoan R; Wyvill K; Okamoto S; Little RF; Tosato G Blood; 2001 Apr; 97(7):2173-6. PubMed ID: 11264189 [TBL] [Abstract][Full Text] [Related]
29. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA. Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306 [TBL] [Abstract][Full Text] [Related]
30. Linking the Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to human malignancies. Kalt I; Masa SR; Sarid R Methods Mol Biol; 2009; 471():387-407. PubMed ID: 19109790 [TBL] [Abstract][Full Text] [Related]
31. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan. Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946 [TBL] [Abstract][Full Text] [Related]
32. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Wen KW; Damania B Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473 [TBL] [Abstract][Full Text] [Related]
33. KSHV-associated multicentric Castleman disease: A tangle of different entities requiring multitarget treatment strategies. Carbone A; De Paoli P; Gloghini A; Vaccher E Int J Cancer; 2015 Jul; 137(2):251-61. PubMed ID: 24771491 [TBL] [Abstract][Full Text] [Related]
34. Monoclonality or oligoclonality of human herpesvirus 8 terminal repeat sequences in Kaposi's sarcoma and other diseases. Judde JG; Lacoste V; Brière J; Kassa-Kelembho E; Clyti E; Couppié P; Buchrieser C; Tulliez M; Morvan J; Gessain A J Natl Cancer Inst; 2000 May; 92(9):729-36. PubMed ID: 10793109 [TBL] [Abstract][Full Text] [Related]
35. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Aoki Y; Jaffe ES; Chang Y; Jones K; Teruya-Feldstein J; Moore PS; Tosato G Blood; 1999 Jun; 93(12):4034-43. PubMed ID: 10361100 [TBL] [Abstract][Full Text] [Related]
36. Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Zhang YJ; Bonaparte RS; Patel D; Stein DA; Iversen PL Mol Cancer Ther; 2008 Mar; 7(3):712-20. PubMed ID: 18347156 [TBL] [Abstract][Full Text] [Related]
37. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. Suthaus J; Adam N; Grötzinger J; Scheller J; Rose-John S Eur J Cell Biol; 2011; 90(6-7):495-504. PubMed ID: 21176991 [TBL] [Abstract][Full Text] [Related]
38. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology. Li S; Bai L; Dong J; Sun R; Lan K Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134 [TBL] [Abstract][Full Text] [Related]